Influenzae Virus Vaccine,Irbesartan, Interferon Alpha 2b, Isosorbide Dinitrate, Itopride Hcl, Isoprenaline, Invert Sugar Saline,Isosorbide-5-Mononitrate With Aspirin, Ivermectin, Interferons, Isopropamide, Isoniazid, Irinotecan, Itraconazole, Isotretinoin, Isoxsuprine, Ibuprofen, Ketorolac Tromethamine, Kanamycin, Keratolytics And Cleanserss, Taj Pharmaceuticals Ltd. , Pharmaceuticals Products, Diseases, Generic Index, Taj Generic, API, Manufacturing, Pharmacological Index, Generic Medicines, API Manufacturing, manufacturing

HOME >> MEDIA

Pharma Industry News :

The latest Pharma Industry News & articles published daily. Includes news on pharmaceutical companies, mergers and acquisitions, drug development, export and import of drugs, legislation, advertising and influence.

Taj Pharma offers accurate, readable and informative news reports every day.

Corporate News and Press Release - Pharmaceuticals

2010

« previous
21 22 23 24 25 26 27 28 29 30 next »

Aug 14 2008	Indian Generic Manufacturing Company receives Food and Drug Administration approval for manufacturing of Generic Influenzae Virus Vaccine
Aug 22 2008	Indian Pharmaceuticals Company Taj Pharmaceuticals receives FDA approval for Generic Irbesartan
Aug 22 2008	Taj Pharma India today receives tentative FDA (Food and Drug Administration) approval for generic Interferon Alpha 2b
Aug 22 2008	Taj Pharmaceuticals bags FDA approval for generic Isosorbide Dinitrate
Aug 28 2008	FDA approval given for Itopride Hcl to Indian Drug Company Taj Pharmaceuticals
Aug 22 2008	Indian Pharmaceuticals Company Taj Pharmaceuticals receives FDA approval for Generic Isoprenaline
Aug 22 2008	Taj Pharma India today receives tentative FDA (Food and Drug Administration) approval for generic Invert Sugar Saline
Aug 22 2008	Taj Pharmaceuticals bags FDA approval for generic Isosorbide-5-Mononitrate With Aspirin
Aug 28 2008	Taj Pharma India today receives tentative FDA (Food and Drug Administration) approval for generic Ivermectin
Aug 22 2008	Indian Generic Manufacturing Company receives Food and Drug Administration approval for manufacturing of Generic Interferons
Aug 22 2008	Indian Pharmaceuticals Company Taj Pharmaceuticals receives FDA approval for Generic Isopropamide
Aug 22 2008	Taj Pharma India today receives tentative FDA (Food and Drug Administration) approval for generic Isoniazid
Aug 22 2008	Indian Generic Manufacturing Company receives Food and Drug Administration approval for manufacturing of Generic Irinotecan
Aug 28 2008	Taj Pharma India today receives tentative FDA (Food and Drug Administration) approval for generic Itraconazole
Aug 28 2008	Indian Generic Manufacturing Company receives Food and Drug Administration approval for manufacturing of Generic Isotretinoin
Aug 28 2008	Indian Pharmaceuticals Company Taj Pharmaceuticals receives FDA approval for Generic Isoxsuprine
Aug 6 2008	Indian Generic Manufacturing Company receives Food and Drug Administration approval for manufacturing of Generic Ibuprofen
Sept 10 2008	FDA approval given for Ketorolac Tromethamine to Indian Drug Company Taj Pharmaceuticals
Sept 10 2008	Taj Pharma India today receives tentative FDA (Food and Drug Administration) approval for generic Kanamycin
Sept 10 2008	Taj Pharmaceuticals bags FDA approval for generic Keratolytics And Cleansers
	« previous 21 22 23 24 25 26 27 28 29 30 next »

Growing Stronger, Growing
Better

Generics

Taj Generics A generic drug (generic drugs, short: generics) is a drug which is produced and distributed without patent protection. The generic drug may still have a patent on the formulation but not on the active ingredient more...

Generics Index AZ Generics List, 5-Aminosalicylic Acid, 5 Fluorouracil, Abciximab, Acarbose, more...

Pharmacological Index Alimentary System, Anti-allergics, Antibiotics, Cardiovascular System, Endocrine System more...

Generic Manufacturer Test Equipment and Facilities : The manufacturing facilities are based in Valsad (Gujarat) and Raigad (Raigarh, Maharashtra) and operated by Taj Pharmaceuticals Ltd more...

Generic Market Taj Pharmaceuticals Ltd is keen to capitalize on new opportunities emerging in the generics market. The company is right now focusing on dermatology, respiratory and cardiovascular segments more...

And Many More Generics Products

Print page Send by mail